Blood Test Can Identify Prostate Cancer Patients Who Are Not Likely to Respond to EnzalutamideAlice Goodman
Researchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods. New research shows that the Prostate ScreeningEpiSwitch(PSE)blood testis 94 percent accurate—beating the currently used prostate-specific antigen (PSA...
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment. The new research paves the way for information from ablood testto informprostate cancer treatmentin f...
population-level screening: the ability to detect multiple deadly cancer types with a single test that has a very low false positive rate, and the ability to identify where in the body the cancer is located with high accuracy to help healthcare providers to direct next step...
The Galleri multi-cancer early detection test is a proactive tool to screen for cancer. With a simple blood draw, the Galleri test can identify DNA shed by cancer cells, which can act as a unique “fingerprint” of cancer, to help screen for some ...
GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generati...
A study published in the British Medical Journal this month found that routine screening for prostate cancer through a PSA test does more harm than good, because it can produce false positives, or lead to the overtreatment of cancers that were never likely to cause problems or be fatal. A ...
An “assay” is the technical term for a test like this, where scientists identify and measure quantities of specific components. Drug tests and COVID-19 tests use their own assays. The PanSeer assay is very new and strictly in the exploration phase, the researchers emphasize. It has promisin...
provides that link and, with it, glimpses into the future of oncology practice. It defines an approach to identify mechanisms that are associated with tumor cells evading drug treatment for men with castration-resistant prostate cancer that is resistance to abiraterone, all with a blood test....
In certain embodiments, a blood test may utilized to identify the presence of a cancer such as, e.g., a melanoma or glioma (e.g., an astrocytoma, a glioblastoma multiforme) in a human patient. In particular, increased p-STAT3 expression by peripheral blood mononuclear cells is selectively ...